Katherine Choe

Katherine Choe is a Principal Scientist in Immunology at Kymera Therapeutics, with a background in Oncology Biology. Prior experience includes serving as a Senior Scientist and Scientist at the same company, and as an American Cancer Society Postdoctoral Fellow at Dana-Farber Cancer Institute. At Dana-Farber, Katherine executed significant research on chromosomal instability and tumorigenesis, leading to successful grant writing totaling approximately $350,000 and mentorship of junior scientists. Earlier, at Penn State College of Medicine, Katherine developed a project identifying a new target for cancer therapeutics and contributed to various publications while mentoring multiple students and technicians. Katherine holds a Ph.D. in Biomedical Sciences from Penn State College of Medicine and a B.S. in Pharmacology and Toxicology from the University of the Sciences in Philadelphia.